Phaius fimbriatus
Phaius fimbriatus · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Phaius fimbriatus is a botanical species currently being investigated for its significant therapeutic potential in managing metabolic and hepatic disorders. Recent research focuses on the pharmacological effects of its methanol extract (CfME) against various systemic conditions. This plant shows promise in addressing complications such as chronic hepatitis and hepatomegaly through its bioactive compounds. Furthermore, studies suggest that CfME may offer protective benefits for patients suffering from gastric ulcers and insulin resistance. Understanding the medicinal properties of Phaius fimbriatus provides critical insights into developing new treatments for these complex health issues.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Not available
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Distribution
Identification
Biological Activities
Compounds
Conditions
Phaius fimbriatus, identified in the research as Calanthe fimbriata, demonstrates potent antidiabetic activity by improving insulin resistance and restoring liver function. The plant extract also exerts strong antihyperglycemic activity in both OGTT and STZ-induced diabetic models. Furthermore, it effectively treats elevated levels of ALT and AST to support hepatoprotective benefits. The medicinal properties of the plant extend to the successful treatment of TG by decreasing triglyceride levels. Collectively, these effects highlight its significant therapeutic potential in managing metabolic and hepatic markers.
Preparations
Phaius fimbriatus, referred to in the study as Calanthe fimbriata, is prepared as a methanol extract known as CfME. This specific extract is derived from the roots of the plant, which is traditionally utilized in Tujia ethnic medicine. The research focuses on evaluating the antidiabetic and hepatoprotective properties of this methanol extract. Through various tests, the study demonstrates how CfME functions to improve glucose utilization and liver function. Ultimately, the preparation of this methanol extract serves as the central subject for investigating its medicinal potential.